<SEC-DOCUMENT>0001104659-20-118552-index.html : 20201027
<SEC-HEADER>0001104659-20-118552.hdr.sgml : 20201027
<ACCEPTANCE-DATETIME>20201027161151
ACCESSION NUMBER:		0001104659-20-118552
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20201027
DATE AS OF CHANGE:		20201027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TITAN PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000910267
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943171940
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-249550
		FILM NUMBER:		201264262

	BUSINESS ADDRESS:	
		STREET 1:		400 OYSTER POINT BLVD
		STREET 2:		SUITE 505
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		6502444990

	MAIL ADDRESS:	
		STREET 1:		400 OYSTER POINT BLVD
		STREET 2:		SUITE 505
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>tm2033419-5_s1a.htm
<DESCRIPTION>S-1/A
<TEXT>
Document 1 - file: tm2033419-5_s1a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.10
<SEQUENCE>2
<FILENAME>tm2033419d5_ex4-10.htm
<DESCRIPTION>EXHIBIT 4.10
<TEXT>
Document 2 - file: tm2033419d5_ex4-10.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.11
<SEQUENCE>3
<FILENAME>tm2033419d5_ex4-11.htm
<DESCRIPTION>EXHIBIT 4.11
<TEXT>
Document 3 - file: tm2033419d5_ex4-11.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lg_titanpharma-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: lg_titanpharma-4clr.jpg

</DOCUMENT>
</SEC-DOCUMENT>